Hypha Labs, Inc. Overview
Pro stress-test →Hypha Labs develops and commercializes the Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. The company is a biotechnology innovator developing revolutionary technologies to disrupt the functional mushroom industry, with a portfolio of patents covering its AI-driven Mushroom Accelerator and proprietary MicroPearls™ delivery system.
Strategic Profile
Pro stress-test →In April 2026, Hypha Labs announced a significant partnership with Mycology Resources, LLC combining Hypha's proprietary Mushroom Accelerator technology and MicroPearls™ delivery system with Mycology Resources' scientific cultivation expertise, ingredient development capabilities, and international distribution network. The partnership enables rapid production of bioavailable Micro-Pearls in just 8 days, with the first new strains scheduled for launch in 2026. Hypha Labs also reports partnerships with Tryptomics for on-site analytical testing, metabolomics, and genetics support, and with Automated Technical Services to design a commercial-scale Mushroom Accelerator for nutraceutical ingredient production.
Competitive Landscape
Pro stress-test →Hypha Labs competes in the emerging functional mushroom bioreactor and ingredient space. The company targets the rapidly expanding functional mushroom market (projected to exceed $76 billion by 2033), competing with traditional dried mushroom products and other mushroom cultivation technologies. Direct biotech competitors include private cultivation specialists and ingredient suppliers; substitute products range from traditional dried mushrooms to other adaptogenic supplements. The partnership with Mycology Resources and Tryptomics positions Hypha for scaled commercial ingredient production and distribution.
Industry Context
Hypha Labs, Inc. operates in Functional mushroom bioreactor systems.
Key facts
Founded: 2010 · Headquarters: Las Vegas, Nevada · Employees: N/A · Revenue: N/A · Market cap: $3.4M